Exclusive

Publication

Byline

Location

Revolution Medicines' Daraxonrasib Redefines Survival In Pancreatic Cancer; Stock Up

India, May 31 -- Revolution Medicines, Inc. (RVMD) unveiled pivotal Phase 3 results from its RASolute 302 trial of Daraxonrasib in previously treated metastatic pancreatic ductal adenocarcinoma, showi... Read More


A Perfect Circle Return With New Single 'Starless'

India, May 31 -- A Perfect Circle, who are set to embark on a tour of Europe and the U.K. next week, have shared a new song, "Starless," just their second new release since their 2018 album, Eat the E... Read More


J&J Phase 1b/2 OrigAMI-4: Subcutaneous Amivantamab Shows 42% ORR In Head & Neck Cancer

India, May 31 -- Johnson & Johnson (JNJ) announced pivotal results from the Phase 1b/2 OrigAMI-4 study, which evaluated subcutaneous amivantamab with hyaluronidase-lpuj in patients with advanced head ... Read More


J&J Phase 3 : Apalutamide + Hormone Therapy Before & After Surgery Improves Prostate Cancer Outcomes

India, May 31 -- Johnson & Johnson (JNJ) announced results from the final analysis of the Phase 3 PROTEUS study, evaluating apalutamide plus hormone therapy (androgen deprivation therapy, ADT) given f... Read More


Hong Kong Shares Tipped To Open In The Green

India, May 31 -- The Hong Kong stock market on Friday snapped the three-day slide in which it had slumped almost 600 points or 2.4 percent. The Hang Seng Index now sits just above the 25,180-point pla... Read More


Pfizer's BRAFTOVI Combo Nearly Doubles PFS In BRAF V600E Metastatic Colorectal Cancer

India, May 31 -- Pfizer Inc. (PFE) announced detailed progression-free and overall survival results from Cohort 3 of the Phase 3 BREAKWATER trial. This randomized cohort evaluated BRAFTOVI (encorafeni... Read More


Rebound Anticipated For China Stock Market

India, May 31 -- The China stock market headed south again on Friday, one day after ending the two-day slide in which it had dropped almost 60 points or 1.3 percent. The Shanghai Composite Index now s... Read More


Eli Lilly's Retevmo Phase 3 LIBRETTO-432 Cuts Recurrence Risk 83% In RET+ Early-Stage NSCLC

India, May 31 -- Eli Lilly and Co. (LLY) announced results from the Phase 3 LIBRETTO-432 clinical trial of Retevmo (selpercatinib) as adjuvant therapy versus placebo in patients with early-stage (IB-I... Read More


South Korea Has $26.95 Billion Trade Surplus In May

India, May 31 -- South Korea posted a seasonally adjusted merchandise trade surplus of $26.95 billion in May, Statistics Korea said on Monday.That beat expectations for a surplus of $24.30 billion and... Read More


Australia Manufacturing Sector Ebbs In May - S&P Global

India, May 31 -- The manufacturing sector in Australia continued to expand in May, albeit at a slower rate, the latest survey from S&P Global revealed on Monday with a manufacturing PMI score of 50.7.... Read More